Skip to main content
. 2020 Nov 4;303(1):181–188. doi: 10.1007/s00404-020-05801-1

Table 1 .

Patient characteristics

Patient collective Tuebingen TissuGlu®
number | percentage respective mean (SD)
Control
number | percentage respective mean (SD)
Patients 8 6
Breast removal 8 7*
Gender (w/m) 7 / 1 6 / 0
Age [years] 60.4 (14.7) 62.0 (11.5)
BMI [kg/m2] 28.9 (4.9) 24.4 (2.3)
Mastectomy 2 | 18% 0 | 0%
Mastectomy + SLNB (n | %) 6 | 72% 7 | 100%
Weight of ablated tissue [g] 602 (332) 426 (157)
Number of lymph nodes removed 3.1 (3.1) 3.7 (3.1)
History of smoking
Never smoked 5 | 63% 3 | 50%
Active smoker 3 | 38% 2 | 33%
Stopped smoking 0 | 0% 1 | 17%
Pre-treatment
Chemotherapy 2 | 25% 0 | 0%
Radiotherapy 2 | 25% 2 | 33%
Antihormonal therapy 1 | 13% 2 | 33%

* one patient with bilateral mastectomy